420 with CNW — Federally Funded Research Finds AUD Is Lower in States Where Cannabis is Legal
Research from the University of Colorado, which was recently published in the publication “Psychological Medicine,” found that recreational decriminalization was linked to increased marijuana use and reduced alcohol use disorder (AUD) symptoms but wasn’t linked to other maladaptations. The researchers advised, nevertheless, that this information is difficult to assess and deserves exploratory research in future studies. Although their results show that marijuana consumption is not risky, the researchers could not pinpoint major variations in these bad consequences as effects of legalizing marijuana.
They found that inasmuch as there was a negligible difference in average alcohol intake, individuals living in areas where cannabis was legal seemed more unlikely to get injured when they were under alcohol influence versus their twins who resided in regions where cannabis was still prohibited.
Additionally, in a study published in “PLOS One” last year, researchers from Michigan State University suggested that in states where marijuana is legal, cannabis sales volumes could be preceded by the increasing incidences of marijuana onsets for older individuals but not for barely legal individuals who cannot purchase recreational cannabis in a retail outlet.
Based on recent federally funded research, individuals living in regions where recreational cannabis is allowed showed lower levels of AUD than those who reside in places where cannabis is still criminalized. According to the study, young individuals who spent much of their puberty under legalization were neither more nor less likely to have used marijuana at 15 years of age than young people who spent minimal or no period under legalization.
Cannabis usage rates among teenagers were steady through 2022, based on the latest publicly financed Monitoring the Future poll, despite additional regions decriminalizing the substance and the ending of pandemic prohibitions that held many children back home under their guardians and parents.
Another study, published in the “American Journal of Preventive Medicine,” found no link between rising youth cannabis use and state-level decriminalization. Marijuana use disorder could be associated in some cannabis users with issues such as the use of other drugs, cognitive function, mental problems, motivation, interpersonal interactions and job performance.
Based on the findings of researchers who evaluated a broad spectrum of outcomes, such as other substance consumption, drug dependency, disordered nature, exacerbating as well as legal difficulties, relational agreement, job involvement, civic participation and cognition, the research, which was financed by the National Institutes of Health (NIH), concluded that pursuing proven potential risks rather than concentrating on availability could be the most effective strategy to carry out prevention and intervention efforts.
As more of these studies document the wide-ranging benefits of marijuana and its constituent compounds, industry players such as Flora Growth Corp. (NASDAQ: FLGC) will gradually be perceived a lot more fondly than prohibitionists currently give them credit for.
NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
Research from the University of Colorado, which was recently published in the publication “Psychological Medicine,” found that recreational decriminalization was linked to increased marijuana use and reduced alcohol use disorder (AUD) symptoms but wasn’t linked to other maladaptations. The researchers advised, nevertheless, that this information is difficult to assess and deserves exploratory research in future studies. Although their results show that marijuana consumption is not risky, the researchers could not pinpoint major variations in these bad consequences as effects of legalizing marijuana.
They found that inasmuch as there was a negligible difference in average alcohol intake, individuals living in areas where cannabis was legal seemed more unlikely to get injured when they were under alcohol influence versus their twins who resided in regions where cannabis was still prohibited.
Additionally, in a study published in “PLOS One” last year, researchers from Michigan State University suggested that in states where marijuana is legal, cannabis sales volumes could be preceded by the increasing incidences of marijuana onsets for older individuals but not for barely legal individuals who cannot purchase recreational cannabis in a retail outlet.
Based on recent federally funded research, individuals living in regions where recreational cannabis is allowed showed lower levels of AUD than those who reside in places where cannabis is still criminalized. According to the study, young individuals who spent much of their puberty under legalization were neither more nor less likely to have used marijuana at 15 years of age than young people who spent minimal or no period under legalization.
Cannabis usage rates among teenagers were steady through 2022, based on the latest publicly financed Monitoring the Future poll, despite additional regions decriminalizing the substance and the ending of pandemic prohibitions that held many children back home under their guardians and parents.
Another study, published in the “American Journal of Preventive Medicine,” found no link between rising youth cannabis use and state-level decriminalization. Marijuana use disorder could be associated in some cannabis users with issues such as the use of other drugs, cognitive function, mental problems, motivation, interpersonal interactions and job performance.
Based on the findings of researchers who evaluated a broad spectrum of outcomes, such as other substance consumption, drug dependency, disordered nature, exacerbating as well as legal difficulties, relational agreement, job involvement, civic participation and cognition, the research, which was financed by the National Institutes of Health (NIH), concluded that pursuing proven potential risks rather than concentrating on availability could be the most effective strategy to carry out prevention and intervention efforts.
As more of these studies document the wide-ranging benefits of marijuana and its constituent compounds, industry players such as Flora Growth Corp. (NASDAQ: FLGC) will gradually be perceived a lot more fondly than prohibitionists currently give them credit for.
NOTE TO INVESTORS: The latest news and updates relating to Flora Growth Corp. (NASDAQ: FLGC) are available in the company’s newsroom at https://cnw.fm/FLGC
Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW420, wherever published or re-published: http://CNW.fm/Disclaimer
